Balyasny Asset Management
RBOT

Balyasny Asset Management’s Vicarious Surgical RBOT Stock Holding History

Balyasny Asset Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,022
Closed -$155K – 3097
2022
Q1 		$155K Buy
+1,022
New +$190K ﹤0.01% 2075
2021
Q3 		– Sell
-3,333
Closed -$997K – 2339
2021
Q2 		$997K Buy
+3,333
New +$993K ﹤0.01% 1273

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management's RBOT Position: Q2 2022 in Review

Balyasny Asset Management sold out of Vicarious Surgical (RBOT) in Q2 2022, closing a stake of 1,022 shares — an estimated $155K sold.

Balyasny Asset Management first reported a position in RBOT in Q2 2021 and held it in 2 quarters. The position peaked at $997K in Q2 2021. 79 funds tracked by Wall St. Rank hold RBOT as of Q2 2022.

  • Balyasny Asset Management reported no remaining Vicarious Surgical position as of Q2 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 1,022 Vicarious Surgical shares in Q2 2022, an estimated $155K.
  • Balyasny Asset Management first reported a position in Vicarious Surgical in Q2 2021 and held it in 2 quarters.
  • Balyasny Asset Management's Vicarious Surgical position peaked at $997K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2022.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.